Close

Roth Capital Reaffirms Regeneron (REGN) at 'Buy'; Dupilumab BLA in AD Key Next Step in Development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. INTC


Go back to Roth Capital Reaffirms Regeneron (REGN) at 'Buy'; Dupilumab BLA in AD Key Next Step in Development
Regeneron (NASDAQ: REGN) Delayed: 890.68 -15.86 (1.75%)
Previous Close $906.54    52 Week High $592.36 
Open $911.09    52 Week Low $325.35 
Day High $915.00    P/E 233.77 
Day Low $876.75    EPS $3.81 
Volume 576,551